Lysozyme nephropathy in chronic myelomonocytic leukemia
Abstract Lysozyme nephropathy is a frequently unrecognized cause of renal disease in chronic myelomonocytic leukemia and may serve as a novel indication for treatment in this patient population. We demonstrate that in newly diagnosed CMML patients, plasma lysozyme levels are positively correlated wi...
Main Authors: | Ami B. Patel, Rodney R. Miles, Michael W. Deininger |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-06-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.2188 |
Similar Items
-
Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: Successful treatment for new and rare entity
by: Mouna Jerbi, et al.
Published: (2021-01-01) -
An unusual case of chronic lymphocytic leukemia with trisomy 12 presenting with prolymphocytic transformation and t(8;21)(q22;q22)
by: Mishi Bhushan, et al.
Published: (2021-04-01) -
Renal Thrombotique microangiopathy: An unusual renal involvement in Niemann‐Pick disease type B
by: Mouna Jerbi, et al.
Published: (2020-12-01) -
TP-0903 is active in models of drug-resistant acute myeloid leukemia
by: Jae Yoon Jeon, et al.
Published: (2020-12-01) -
Metastatic renal cell carcinoma complicated by right atrial thrombus
by: Hafiz Muhammad Abrar Jeelani, et al.
Published: (2021-04-01)